- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
An open-label, multicenter, phase 1b/2 study of E7386 in combination with pembrolizumab in previously treated subjects with selected solid tumors
This study is testing new combinations of medicines (E7386 with pembrolizumab, and sometimes with lenvatinib) for advanced bowel cancer, melanoma, and liver cancer. Researchers want to see if these combinations are safe and if they can shrink tumors.
For: colorectal cancer · melanoma · hepatocellular carcinomaSpain - Active not recruitingPHASE1
Study of E7386 in Participants With Selected Advanced Neoplasms
This study is testing a new medicine, E7386, for people with certain advanced cancers. Researchers want to see if it's safe, what side effects it might cause, and find the best dose to use in future studies. It's an early-stage trial.
For: Advanced NeoplasmsUnited States · United Kingdom